Fiche société
The Children's Hospital of Zhejiang University School of Medicine
Traitements, essais et publications liés.
Traitements5programmes
Essais4liés
Publications4liées
SourceDBlocale
Traitements
5| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| TelitaciceptThis is a multi-center, open-label, phase I study. | Lupus, Myasthénie | Non applicable | À vérifier | China | À vérifier |
| TelitaciceptThis is a multi-center, open-label, phase I study. | Lupus | Phase 1 | À vérifier | China | À vérifier |
| TelitaciceptThis is a multi-center, open-label, phase I study. | Myasthénie | Phase 3 | À vérifier | United States, Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, France, Georgia, Italy, Japan, Poland, Spain | À vérifier |
| TelitaciceptThis is a multi-center, open-label, phase I study. | Myasthénie | Phase 3 | À vérifier | China | À vérifier |
| TelitaciceptThis is a multi-center, open-label, phase I study. | Myasthénie | Non applicable | À vérifier | China | À vérifier |
Essais cliniques
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Telitacicept | Myasthénie | Non applicable | NCT07298928 | A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis | NOT_YET_RECRUITING |
| Telitacicept | Myasthénie | Phase 3 | NCT07249632 | A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) | RECRUITING |
| Telitacicept | Myasthénie | Phase 3 | NCT06456580 | A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) | RECRUITING |
| Telitacicept | Lupus | Phase 1 | NCT05247203 | Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus | COMPLETED |
Publications
4| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Telitacicept | Comparative effectiveness and predictors of SRI-4 and LLDAS attainment in active systemic lupus erythematosus: a real-world study of telitacicept versus belimumab. | Clinical rheumatology | ||
| Telitacicept | Research on the safety and efficacy of telitacicept in the treatment of IgA nephropathy in children. | Renal failure | ||
| Telitacicept | Case Report: Telitacicept in the treatment of refractory juvenile idiopathic arthritis: clinical experience from three cases. | Frontiers in pediatrics | ||
| Telitacicept | Efficacy and safety of BAFF/APRIL-pathway inhibitors versus placebo in adults with IgA nephropathy: a systematic review with pairwise and network meta-analysis. | BMC nephrology |